COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 2746: Articles 27451-27460  | Next

Current Evidence of the Pharmacological Treatments for Novel Coronavirus Disease 2019 (COVID-19) A Scoping Review
Yamaji, N., Ohde, S., Kobayashi-Cuya, K. E., Saito, S., Takahashi, O.
10.1101/2020.05.12.20093997 — Posted: 2020-05-18
Sarilumab use in severe SARS-CoV-2 pneumonia
Gremese, E., Cingolani, A., Bosello, S. L., Alivernini, S., Tolusso, B., Perniola, S., Landi, F., Pompili, M., Murri, R., Santoliquido, A., Garcovich, M., Sali, M., De Pascale, G., Gabrielli, M., Biscetti, F., Montalto, M., Tosoni, A., Gambassi, G., Rapaccini, G. L., Iaconelli, A., Zileri Dal Verme, L., Petricca, L., Fedele, A. L., Lizzio, M. M., Tamburrini, E., Natalello, G., Gigante, L., Bruno, D., Verardi, L., Taddeo, M., Calabrese, A., Lombardi, F., Bernabei, R., Cauda, R., Franceschi, F., Landolfi, R., Richeldi, L., Sanguinetti, M., Fantoni, M., Antonelli, M., Gasbarrini, A.
10.1101/2020.05.14.20094144 — Posted: 2020-05-18
Transmission of aerosols through pristine and reprocessed N95 respirators
Chen, P. Z., Ngan, A., Manson, N., Maynes, J. T., Borschel, G. H., Rotstein, O. D., Gu, F. X.
10.1101/2020.05.14.20094821 — Posted: 2020-05-18
Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea
Kim, M. S., Jang, S.-W., Park, Y.-K., Kim, B.-o., Hwang, T.-H., Kang, S. H., Kim, W. J., Park, H.-W., Yang, W., Jang, J., An, M. H.
10.1101/2020.05.13.20094193 — Posted: 2020-05-18 Discussion: Onsite
Quantitative Analysis of the Effectiveness of Public Health Measures on COVID-19 Transmission
Silva, T. C., Anghinoni, L., Zhao, L.
10.1101/2020.05.15.20102988 — Posted: 2020-05-18
SARS-CoV-2 Antibody responses do not predict COVID-19 disease severity
Phipps, W. S., SoRelle, J. A., Li, Q.-Z., Mahimainathan, L., Araj, E., Markantonis, J., Lacelle, C., Balani, J., Parikh, H., Solow, E. B., Karp, D. R., Sarode, R., Muthukumar, A.
10.1101/2020.05.15.20103580 — Posted: 2020-05-18
Symptomatic SARS-CoV-2 infections display specific IgG Fc structures
Chakraborty, S., Edwards, K., Buzzanco, A. S., Memoli, M. J., Sherwood, R., Mallajosyula, V., Xie, M. M., Gonzalez, J., Buffone, C., Kathale, N., Providenza, S., Jagannathan, P., Andrews, J. R., Blish, C. A., Krammer, F., Dugan, H., Wilson, P. C., Pham, T. D., Boyd, S. D., Zhang, S., Taubenberger, J. K., Morales, T., Schapiro, J. M., Parsonnet, J., Wang, T. T.
10.1101/2020.05.15.20103341 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Evaluation of the US governors decision when to issue stay-at-home orders
Djulbegovic, B., Weiss, D. J., Hozo, I.
10.1101/2020.05.14.20093633 — Posted: 2020-05-18
A citizen science initiative for open data and visualization of COVID-19 outbreak in Kerala, India
Ulahannan, J. P., Narayanan, N., Thalhath, N., Prabhakaran, P., Chaliyeduth, S., Suresh, S. P., Mohammed, M., E, R., Joseph, S., Balakrishnan, A., Uthaman, J., Karingamadathil, M., Thomas, S. T., Sureshkumar, U., Balan, S., Nanoth Vellichirammal, N.
10.1101/2020.05.13.20092510 — Posted: 2020-05-18
Interpretable Artificial Intelligence for COVID-19 Diagnosis from Chest CT Reveals Specificity of Ground-Glass Opacities
Warman, A., Warman, P., Sharma, A., Parikh, P., Warman, R., Viswanadhan, N., Chen, L., Mohapatra, S., Mohapatra, S., Sapiro, G.
10.1101/2020.05.16.20103408 — Posted: 2020-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).